文献速递消化道肿瘤与早癌消化内镜

乳腺癌与结直肠癌风险之间的关联

Association between breast cancer and the risk of colorectal cancer.
PubMed 文献 · Gastrointest Endosc · 2017-04-20

该系统评价纳入37项回顾性队列研究和8项病例对照研究,计算乳腺癌患者结直肠癌的合并患病率及比值比。结果显示乳腺癌患者结直肠癌合并事件率为0.7%,<50岁患者风险升高(OR 2.5),<45岁女性风险亦升高(OR 2.3)。作者认为乳腺癌患者不应采用与一般人群不同的结直肠癌筛查间隔,<50岁患者可考虑45岁开始筛查。

要点

  • 乳腺癌患者结直肠癌合并事件率为0.7%(95%CI 0.6%-0.9%,I²=97%)。
  • <50岁乳腺癌患者结直肠癌风险升高(OR 2.5,95%CI 1.7-3.5,P=.001)。
  • 作者认为乳腺癌患者不应采用与一般人群不同的结直肠癌筛查间隔。

核心结论

  • 作者认为乳腺癌患者不应采用与一般人群不同的结直肠癌筛查间隔。
  • 作者提出<50岁乳腺癌患者可考虑在45岁开始结直肠癌筛查。

研究设计与样本

  • 系统评价纳入37项回顾性队列研究和8项病例对照研究。
  • 共纳入1,055,917例乳腺癌患者,检出9097例结直肠癌。
  • 采用随机效应模型计算合并患病率和比值比(OR),报告95%置信区间(CI)。

主要发现

  • 乳腺癌患者结直肠癌合并事件率为0.7%(95%CI 0.6%-0.9%;I²=97%)。
  • 4项病例对照研究(17,873例乳腺癌患者 vs 70,366例对照)中,乳腺癌患者46例结直肠癌 vs 对照272例结直肠癌(OR 1.2;95%CI 0.4%-3.7%;P=.7)。
  • 6项研究(1087例乳腺癌患者 vs 1356例对照)中,进展期腺瘤62例 vs 47例(OR 1.5;95%CI 0.97-2.2;P=.07)。
  • <50岁乳腺癌患者(4项研究,N=64,706)合并OR升高(OR 2.5;95%CI 1.7-3.5;P=.001)。
  • <45岁女性(3项研究,N=92,594)风险升高(OR 2.3;95%CI 1.7-2.6;P<.001)。

临床怎么用

  • 作者认为乳腺癌患者不应采用与一般人群不同的结直肠癌筛查间隔。
  • 作者提出<50岁乳腺癌患者可考虑在45岁开始结直肠癌筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The literature to date has suggested a potential increase in colorectal cancer (CRC) among patients with breast cancer. METHODS: We performed a systematic review of the literature and included 37 retrospective cohort studies and 8 case-control studies. The primary aim was to determine the prevalence of CRC. Secondary aims included analysis of adenomatous polyps and analysis of CRC prevalence by age. We calculated pooled prevalence rates and odds ratios (ORs) using random effects models with 95% confidence intervals (CI). RESULTS: We identified 1,055,917 individuals with breast cancer among whom 9097 cases of CRC were detected. The pooled event rate for CRC was 0.7% (95% CI, 0.6%-0.9%; I2=97%). Four case-control studies reported prevalence of CRC (N=17,873 patients with breast cancer and 70,366 controls), including 46 cases of CRC in the patients with breast cancer, and 272 CRC in the controls (OR, 1.2; 95% CI, 0.4%-3.7%; P = .7). Six studies reported prevalence of advanced adenomas in patients with breast cancer (N=1087) compared with controls (N=1356) with 62 cases of advanced adenomas in patients compared with 47 in the controls (OR, 1.5; 95% CI, 0.97-2.2; P = .07). In patients with breast cancer <50 years old (4 studies, N=64,706), the pooled OR was increased (OR, 2.5; 95% CI, 1.7-3.5; P =.001). In 3 studies of women <45 years old (N=92,594), the risk was increased (OR, 2.3; 95% CI, 1.7-2.6; P < .001). CONCLUSIONS: Patients with breast cancer should not undergo CRC screening at intervals different from the general population. In patients with breast cancer <50 years old, CRC screening should be considered at age 45 years.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Lai JH, Park G, Gerson LB, et al. Association between breast cancer and the risk of colorectal cancer. Gastrointest Endosc. 2017. PMID: 28433614. doi:10.1016/j.gie.2017.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。